To evaluate the role of polymorphonuclear leukocyte (PMN) elastase in pulmonary impairment occurring after operation for esophageal cancer, 10 patients were randomized preoperatively into two equal groups. One group received a placebo infusion and the other, an infusion of the PMN elastase inhibitor ulinastatin. In the placebo group, the mean plasma PMN elastase level increased from 154 ± 23 μg/L preoperatively to 449 ± 56 μg/L at 6 hours postoperatively (p < 0.01), whereas the mean plasma fibronectin concentration decreased from 490 ± 70 μg/mL preoperatively to 265 ± 81 μg/mL on postoperative day 2 (p < 0.01). The mean pulmonary vascular resistance increased markedly from 151 ± 24 dynes · s · cm−5 · m−2 preoperatively to 284 ± 76 dynes · s · cm−5 · m−2 at 6 hours postoperatively (p < 0.01). In the group given ulinastatin, 150,000 units every 12 hours from the start of the operation, the mean PMN elastase value at 6 hours posioperatively was lower (275 ± 66 μg/L; p < 0.01) and the fibronectin level on postoperative days 1 and 2, higher (p < 0.05). A lower pulmonary vascular resistance was noted into day 2 (p < 0.05). Our results suggest that PMN elastase may participate in the development of postoperative pulmonary impairment.
Read full abstract